Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in the U.S.
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.3. Competitive Insights
Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing geriatric population
3.2.1.2. High adoption of minimally invasive procedures
3.2.1.3. Increase in the number of sports and road accidents
3.2.1.4. Increasing geographic reach of market players
3.2.2. Market Restraint Analysis
3.2.2.1. Increase in the number of product recalls
3.2.2.2. Social and ethical issues
3.2.2.3. Slow approval procedures
3.3. U.S. Medical Device Manufacturers Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. U.S. Medical Device Manufacturers Market by Application Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Orthopedic Devices
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Cardiovascular Devices
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.3. Neurology Devices
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.4. Drug Delivery Devices
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5. Ophthalmic Devices
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.6. Nephrology and Urology Devices
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.7. Others
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. Key company market share analysis, 2024
5.3.2. Stryker
5.3.2.1. Company overview
5.3.2.2. Financial performance
5.3.2.3. Product benchmarking
5.3.2.4. Strategic initiatives
5.3.3. Cardinal Health
5.3.3.1. Company overview
5.3.3.2. Financial performance
5.3.3.3. Product benchmarking
5.3.3.4. Strategic initiatives
5.3.4. Eli Lily and Company
5.3.4.1. Company overview
5.3.4.2. Financial performance
5.3.4.3. Product benchmarking
5.3.4.4. Strategic initiatives
5.3.5. Intuitive Surgical
5.3.5.1. Company overview
5.3.5.2. Financial performance
5.3.5.3. Product benchmarking
5.3.5.4. Strategic initiatives
5.3.6. Edwards Lifesciences Corporation
5.3.6.1. Company overview
5.3.6.2. Financial performance
5.3.6.3. Product benchmarking
5.3.6.4. Strategic initiatives
5.3.7. BD
5.3.7.1. Company overview
5.3.7.2. Financial performance
5.3.7.3. Product benchmarking
5.3.7.4. Strategic initiatives
5.3.8. Danaher
5.3.8.1. Company overview
5.3.8.2. Financial performance
5.3.8.3. Product benchmarking
5.3.8.4. Strategic initiatives
5.3.9. 3M
5.3.9.1. Company overview
5.3.9.2. Financial performance
5.3.9.3. Product benchmarking
5.3.9.4. Strategic initiatives
5.3.10. Abbott
5.3.10.1. Company overview
5.3.10.2. Financial performance
5.3.10.3. Product benchmarking
5.3.10.4. Strategic initiatives
5.3.11. Baxter
5.3.11.1. Company overview
5.3.11.2. Financial performance
5.3.11.3. Product benchmarking
5.3.11.4. Strategic initiatives
5.3.12. B. Braun SE
5.3.12.1. Company overview
5.3.12.2. Financial performance
5.3.12.3. Product benchmarking
5.3.12.4. Strategic initiatives
5.3.13. GE HealthCare
5.3.13.1. CompanOverviewew
5.3.13.2. Financial performance
5.3.13.3. Product benchmarking
5.3.13.4. Strategic initiatives
5.3.14. Johnson & Johnson Services, Inc.
5.3.14.1. CompanOverviewew
5.3.14.2. Financial performance
5.3.14.3. Product benchmarking
5.3.14.4. Strategic initiatives
5.3.15. Medtronic
5.3.15.1. Company overview
5.3.15.2. Financial performance
5.3.15.3. Product benchmarking
5.3.15.4. Strategic initiatives
5.3.16. Boston Scientific Corporation
5.3.16.1. CompanOverviewew
5.3.16.2. Financial performance
5.3.16.3. Product benchmarking
5.3.16.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
Table 4 Key companies undergoing acquisitions/expansions
Table 5 Key companies undergoing product launch/approval
Table 6 Key companies undergoing partnership & collaboration
List of Figures
Fig. 1 U.S. Medical Device Manufacturers Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market snapshot
Fig. 8 Competitive landscape
Fig. 9 Market Dynamics
Fig. 10 U.S. Medical Device Manufacturers market: PORTER’s analysis
Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2024 & 2030
Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
Fig. 20 Others market, 2018 - 2030 (USD Billion)
Fig. 21 Key company categorization
Fig. 22 Heat map analysis
Fig. 23 U.S orthopedic devices market share analysis, 2024
Fig. 24 U.S cardiac care devices market share analysis, 2024
Fig. 25 U.S drug delivery devices market share analysis, 2024
Fig. 26 Strategic Framework